{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T16:03:12Z","timestamp":1784822592530,"version":"3.55.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T00:00:00Z","timestamp":1782518400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82571592"],"award-info":[{"award-number":["82571592"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82471426"],"award-info":[{"award-number":["82471426"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Clinical Collaboration Project for Major and Difficult Diseases with Integrated Traditional Chinese and Western Medicine","award":["o. GTCM Integration Letter [2023] No. 250"],"award-info":[{"award-number":["o. GTCM Integration Letter [2023] No. 250"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Ther"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s40120-026-00988-y","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T16:01:01Z","timestamp":1782576061000},"page":"2113-2128","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Extended Preoperative Immunotherapy Duration Reduces the Risk of Myasthenia Gravis Exacerbation for Patients with Thymoma: A Multicenter Retrospective Cohort Study"],"prefix":"10.1007","volume":"15","author":[{"given":"Jialin","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongxi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianglin","family":"Chu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huahua","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhangyu","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liewen","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chongbo","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhitao","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9033-7568","authenticated-orcid":false,"given":"Sushan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,27]]},"reference":[{"issue":"2","key":"988_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S1474-4422(21)00357-4","volume":"21","author":"MG Huijbers","year":"2022","unstructured":"Huijbers MG, Marx A, Plomp JJ, Le Panse R, Phillips WD. Advances in the understanding of disease mechanisms of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21(2):163\u201375. https:\/\/doi.org\/10.1016\/S1474-4422(21)00357-4.","journal-title":"Lancet Neurol"},{"key":"988_CR2","doi-asserted-by":"publisher","first-page":"175628642312132","DOI":"10.1177\/17562864231213240","volume":"16","author":"H Wiendl","year":"2023","unstructured":"Wiendl H, Abicht A, Chan A, et al. Guideline for the management of myasthenic syndromes. Ther Adv Neurol Disord. 2023;16:17562864231213240. https:\/\/doi.org\/10.1177\/17562864231213240.","journal-title":"Ther Adv Neurol Disord"},{"key":"988_CR3","doi-asserted-by":"publisher","first-page":"102895","DOI":"10.1016\/j.jaut.2022.102895","volume":"132","author":"K Chen","year":"2022","unstructured":"Chen K, Li Y, Yang H. Poor responses and adverse outcomes of myasthenia gravis after thymectomy: predicting factors and immunological implications. J Autoimmun. 2022;132:102895. https:\/\/doi.org\/10.1016\/j.jaut.2022.102895.","journal-title":"J Autoimmun"},{"key":"988_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/bs.irn.2025.04.023","volume":"182","author":"N Dragin","year":"2025","unstructured":"Dragin N, Le Panse R. Thymic physiology and pathophysiology in myasthenia gravis. Int Rev Neurobiol. 2025;182:67\u201388. https:\/\/doi.org\/10.1016\/bs.irn.2025.04.023.","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"988_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103875","volume":"24","author":"M Mane-Damas","year":"2025","unstructured":"Mane-Damas M, Schottler AK, Marcuse F, et al. Myasthenia gravis with antibodies against the AChR, current knowledge on pathophysiology and an update on treatment strategies with special focus on targeting plasma cells. Autoimmun Rev. 2025;24(10):103875. https:\/\/doi.org\/10.1016\/j.autrev.2025.103875.","journal-title":"Autoimmun Rev"},{"issue":"2","key":"988_CR6","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/S1474-4422(21)00297-0","volume":"21","author":"AR Punga","year":"2022","unstructured":"Punga AR, Maddison P, Heckmann JM, Guptill JT, Evoli A. Epidemiology, diagnostics, and biomarkers of autoimmune neuromuscular junction disorders. Lancet Neurol. 2022;21(2):176\u201388. https:\/\/doi.org\/10.1016\/S1474-4422(21)00297-0.","journal-title":"Lancet Neurol"},{"key":"988_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2025.04.014","author":"S Wang","year":"2025","unstructured":"Wang S, Zhu M, Dong J, et al. Perioperative safety and efficacy of efgartigimod for thymoma associated myasthenia gravis: a prospective, multicenter, phase\u00a0II clinical trial. J Thorac Oncol. 2025. https:\/\/doi.org\/10.1016\/j.jtho.2025.04.014.","journal-title":"J Thorac Oncol"},{"issue":"6","key":"988_CR8","doi-asserted-by":"publisher","first-page":"2083","DOI":"10.1111\/ene.14820","volume":"28","author":"R Alvarez-Velasco","year":"2021","unstructured":"Alvarez-Velasco R, Gutierrez-Gutierrez G, Trujillo JC, et al. Clinical characteristics and outcomes of thymoma-associated myasthenia gravis. Eur J Neurol. 2021;28(6):2083\u201391. https:\/\/doi.org\/10.1111\/ene.14820.","journal-title":"Eur J Neurol"},{"key":"988_CR9","doi-asserted-by":"publisher","DOI":"10.1093\/ejcts\/ezad179","author":"D Brascia","year":"2023","unstructured":"Brascia D, Lucchi M, Aprile V, et al. Thymectomy in severe (Myasthenia Gravis Foundation of America classes IV-V) generalized myasthenia gravis: is the game really worth the candle? Eur J Cardiothorac Surg. 2023. https:\/\/doi.org\/10.1093\/ejcts\/ezad179.","journal-title":"Eur J Cardiothorac Surg"},{"key":"988_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jss.2020.12.048","volume":"262","author":"Y Huang","year":"2021","unstructured":"Huang Y, Su L, Zhang Y, Guo J, Wang C. Risk factors for postoperative myasthenic crisis after thymectomy in patients with myasthenia gravis. J Surg Res. 2021;262:1\u20135. https:\/\/doi.org\/10.1016\/j.jss.2020.12.048.","journal-title":"J Surg Res"},{"key":"988_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2021.577634","volume":"358","author":"A Uzawa","year":"2021","unstructured":"Uzawa A, Akamine H, Kojima Y, et al. High levels of serum interleukin-6 are associated with disease activity in myasthenia gravis. J Neuroimmunol. 2021;358:577634. https:\/\/doi.org\/10.1016\/j.jneuroim.2021.577634.","journal-title":"J Neuroimmunol"},{"key":"988_CR12","doi-asserted-by":"publisher","DOI":"10.1172\/JCI179742","author":"HJ Kaminski","year":"2024","unstructured":"Kaminski HJ, Sikorski P, Coronel SI, Kusner LL. Myasthenia gravis: the future is here. J Clin Invest. 2024. https:\/\/doi.org\/10.1172\/JCI179742.","journal-title":"J Clin Invest"},{"key":"988_CR13","doi-asserted-by":"publisher","DOI":"10.1155\/ane\/9927870","author":"F Habetswallner","year":"2026","unstructured":"Habetswallner F, Bello L, Biasini F, et al. Identifying red flags in myasthenia gravis diagnosis, reassessment, and myasthenic crisis: an Italian Delphi-based position paper. Acta Neurol Scand. 2026. https:\/\/doi.org\/10.1155\/ane\/9927870.","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"988_CR14","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1212\/WNL.0000000000011124","volume":"96","author":"P Narayanaswami","year":"2021","unstructured":"Narayanaswami P, Sanders DB, Wolfe G, et al. International consensus guidance for management of myasthenia gravis: 2020 update. Neurology. 2021;96(3):114\u201322. https:\/\/doi.org\/10.1212\/WNL.0000000000011124.","journal-title":"Neurology"},{"issue":"3","key":"988_CR15","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.medcli.2023.04.006","volume":"161","author":"DA Garcia Estevez","year":"2023","unstructured":"Garcia Estevez DA, Pardo Fernandez J. Myasthenia gravis. Update on diagnosis and therapy. Med Clin (Barc). 2023;161(3):119\u201327. https:\/\/doi.org\/10.1016\/j.medcli.2023.04.006.","journal-title":"Med Clin (Barc)"},{"issue":"7","key":"988_CR16","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/wnl.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology. 1999;52(7):1487\u20139. https:\/\/doi.org\/10.1212\/wnl.52.7.1487.","journal-title":"Neurology"},{"issue":"5","key":"988_CR17","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mus.22140","volume":"44","author":"S Muppidi","year":"2011","unstructured":"Muppidi S, Wolfe GI, Conaway M, Burns TM, MG Composite and MG-QOL15 Study Group. MG-ADL: still a relevant outcome measure. Muscle Nerve. 2011;44(5):727\u201331. https:\/\/doi.org\/10.1002\/mus.22140.","journal-title":"Muscle Nerve"},{"key":"988_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/1749-8090-8-226","volume":"8","author":"Y Yamada","year":"2013","unstructured":"Yamada Y, Yoshida S, Suzuki H, et al. Efficacy of perioperative high-dose prednisolone therapy during thymectomy in myasthenia gravis patients. J Cardiothorac Surg. 2013;8:226. https:\/\/doi.org\/10.1186\/1749-8090-8-226.","journal-title":"J Cardiothorac Surg"},{"issue":"7","key":"988_CR19","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s00415-020-09770-y","volume":"267","author":"J Vissing","year":"2020","unstructured":"Vissing J, Jacob S, Fujita KP, O\u2019Brien F, Howard JF, REGAIN study group. \u201cMinimal symptom expression\u201d in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab. J Neurol. 2020;267(7):1991\u20132001. https:\/\/doi.org\/10.1007\/s00415-020-09770-y.","journal-title":"J Neurol"},{"issue":"1","key":"988_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/wnl.55.1.16","volume":"55","author":"A Jaretzki III","year":"2000","unstructured":"Jaretzki A III, Barohn RJ, Ernstoff RM, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000;55(1):16\u201323. https:\/\/doi.org\/10.1212\/wnl.55.1.16.","journal-title":"Neurology"},{"key":"988_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jns.2017.10.026","volume":"383","author":"Y Zheng","year":"2017","unstructured":"Zheng Y, Cai YZ, Shi ZY, et al. Different neurologic outcomes of myasthenia gravis with thymic hyperplasia and thymoma after extended thymectomy: a single center experience. J Neurol Sci. 2017;383:93\u20138. https:\/\/doi.org\/10.1016\/j.jns.2017.10.026.","journal-title":"J Neurol Sci"},{"issue":"9","key":"988_CR22","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1097\/JTO.0000000000000663","volume":"10","author":"WD Travis","year":"2015","unstructured":"Travis WD, Brambilla E, Burke AP, Marx A, Nicholson AG. Introduction to the 2015 World Health Organization classification of tumors of the lung, pleura, thymus, and heart. J Thorac Oncol. 2015;10(9):1240\u20132. https:\/\/doi.org\/10.1097\/JTO.0000000000000663.","journal-title":"J Thorac Oncol"},{"issue":"10","key":"988_CR23","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1016\/j.jtho.2023.07.008","volume":"18","author":"A Rimner","year":"2023","unstructured":"Rimner A, Ruffini E, Cilento V, et al. The International Association for the Study of Lung Cancer Thymic Epithelial Tumors Staging Project: An Overview of the Central Database\u00a0Informing Revision of the Forthcoming (Ninth) Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol. 2023;18(10):1386\u201398. https:\/\/doi.org\/10.1016\/j.jtho.2023.07.008.","journal-title":"J Thorac Oncol"},{"issue":"7","key":"988_CR24","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1007\/s00595-024-02806-0","volume":"54","author":"T Suzuki","year":"2024","unstructured":"Suzuki T, Hishida T, Suzuki S, et al. Clinicopathological predictors of postoperative long-term myasthenic status in resected thymoma with myasthenia gravis. Surg Today. 2024;54(7):787\u201394. https:\/\/doi.org\/10.1007\/s00595-024-02806-0.","journal-title":"Surg Today"},{"issue":"8","key":"988_CR25","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1007\/s00268-009-0097-0","volume":"33","author":"C Prokakis","year":"2009","unstructured":"Prokakis C, Koletsis E, Apostolakis E, et al. Modified maximal thymectomy for thymic epithelial tumors: predictors of survival and neurological outcome in patients with thymomatous myasthenia gravis. World J Surg. 2009;33(8):1650\u20138. https:\/\/doi.org\/10.1007\/s00268-009-0097-0.","journal-title":"World J Surg"},{"issue":"3","key":"988_CR26","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1016\/j.ejcts.2006.06.009","volume":"30","author":"IK Park","year":"2006","unstructured":"Park IK, Choi SS, Lee JG, Kim DJ, Chung KY. Complete stable remission after extended transsternal thymectomy in myasthenia gravis. Eur J Cardiothorac Surg. 2006;30(3):525\u20138. https:\/\/doi.org\/10.1016\/j.ejcts.2006.06.009.","journal-title":"Eur J Cardiothorac Surg"},{"key":"988_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2025.110657","volume":"283","author":"H Wu","year":"2025","unstructured":"Wu H, Chu X, Zhong H, et al. Eculizumab as a new option for perioperative treatment in thymoma-associated myasthenia gravis. Clin Immunol. 2025;283:110657. https:\/\/doi.org\/10.1016\/j.clim.2025.110657.","journal-title":"Clin Immunol"},{"key":"988_CR28","doi-asserted-by":"publisher","DOI":"10.1177\/1756286419864497","volume":"12","author":"J Gamez","year":"2019","unstructured":"Gamez J, Salvado M, Carmona F, et al. Intravenous immunoglobulin to prevent myasthenic crisis after thymectomy and other procedures can be omitted in patients with well-controlled myasthenia gravis. Ther Adv Neurol Disord. 2019;12:1756286419864497. https:\/\/doi.org\/10.1177\/1756286419864497.","journal-title":"Ther Adv Neurol Disord"},{"issue":"6","key":"988_CR29","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/icvts\/ivz186","volume":"29","author":"TA Reis","year":"2019","unstructured":"Reis TA, Cataneo DC, Cataneo AJM. Clinical usefulness of prethymectomy plasmapheresis in patients with myasthenia gravis: a systematic review and meta-analysis. Interact Cardiovasc Thorac Surg. 2019;29(6):867\u201375. https:\/\/doi.org\/10.1093\/icvts\/ivz186.","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"988_CR30","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.amjsurg.2012.11.018","volume":"206","author":"AS Wang","year":"2013","unstructured":"Wang AS, Armstrong EJ, Armstrong AW. Corticosteroids and wound healing: clinical considerations in the perioperative period. Am J Surg. 2013;206(3):410\u20137. https:\/\/doi.org\/10.1016\/j.amjsurg.2012.11.018.","journal-title":"Am J Surg"},{"issue":"5","key":"988_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002024","volume":"13","author":"L Fardet","year":"2016","unstructured":"Fardet L, Petersen I, Nazareth I. Common infections in patients prescribed systemic glucocorticoids in primary care: a population-based cohort study. PLoS Med. 2016;13(5):e1002024. https:\/\/doi.org\/10.1371\/journal.pmed.1002024.","journal-title":"PLoS Med"},{"issue":"5","key":"988_CR32","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1111\/1759-7714.13396","volume":"11","author":"W Tian","year":"2020","unstructured":"Tian W, Li X, Tong H, et al. Surgical effect and prognostic factors of myasthenia gravis with thymomas. Thorac Cancer. 2020;11(5):1288\u201396. https:\/\/doi.org\/10.1111\/1759-7714.13396.","journal-title":"Thorac Cancer"},{"issue":"4","key":"988_CR33","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1093\/ejcts\/ezx163","volume":"52","author":"L Xue","year":"2017","unstructured":"Xue L, Wang L, Dong J, et al. Risk factors of myasthenic crisis after thymectomy for thymoma patients with myasthenia gravis. Eur J Cardiothorac Surg. 2017;52(4):692\u20137. https:\/\/doi.org\/10.1093\/ejcts\/ezx163.","journal-title":"Eur J Cardiothorac Surg"},{"key":"988_CR34","doi-asserted-by":"publisher","first-page":"175628642513435","DOI":"10.1177\/17562864251343573","volume":"18","author":"Q Zhang","year":"2025","unstructured":"Zhang Q, Pan X, Bi Z, et al. Comparison of outcomes and postoperative immunotherapy between patients with non-thymomatous and thymomatous myasthenia gravis following thymectomy. Ther Adv Neurol Disord. 2025;18:17562864251343572. https:\/\/doi.org\/10.1177\/17562864251343573.","journal-title":"Ther Adv Neurol Disord"},{"issue":"5","key":"988_CR35","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1093\/ejcts\/ezz334","volume":"57","author":"KJ Na","year":"2020","unstructured":"Na KJ, Hyun K, Kang CH, et al. Predictors of post-thymectomy long-term neurological remission in thymomatous myasthenia gravis: an analysis from a multi-institutional database. Eur J Cardiothorac Surg. 2020;57(5):867\u201373. https:\/\/doi.org\/10.1093\/ejcts\/ezz334.","journal-title":"Eur J Cardiothorac Surg"},{"issue":"5","key":"988_CR36","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/pn-2025-004655","volume":"25","author":"S Jacob","year":"2025","unstructured":"Jacob S, Farrugia ME, Hewamadduma C, et al. Association of British Neurologists (ABN) autoimmune myasthenia gravis management guidelines (2025 update). Pract Neurol. 2025;25(5):422\u201337. https:\/\/doi.org\/10.1136\/pn-2025-004655.","journal-title":"Pract Neurol"},{"issue":"1","key":"988_CR37","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1186\/s13023-022-02454-y","volume":"17","author":"J Zhang","year":"2022","unstructured":"Zhang J, Zhang Z, Zhang H, et al. Thymectomy in ocular myasthenia gravis-prognosis and risk factors analysis. Orphanet J Rare Dis. 2022;17(1):309. https:\/\/doi.org\/10.1186\/s13023-022-02454-y.","journal-title":"Orphanet J Rare Dis"},{"issue":"4","key":"988_CR38","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1007\/s13311-021-01129-z","volume":"18","author":"H Li","year":"2021","unstructured":"Li H, Ruan Z, Gao F, et al. Thymectomy and risk of generalization in patients with ocular myasthenia gravis: a multicenter retrospective cohort study. Neurotherapeutics. 2021;18(4):2449\u201357. https:\/\/doi.org\/10.1007\/s13311-021-01129-z.","journal-title":"Neurotherapeutics"},{"issue":"1","key":"988_CR39","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13019-023-02169-6","volume":"18","author":"P Jiao","year":"2023","unstructured":"Jiao P, Tian WX, Wu FJ, et al. Postoperative clinical outcomes of patients with thymic epithelial tumors after over-3-year follow-up at a single-center. J Cardiothorac Surg. 2023;18(1):77. https:\/\/doi.org\/10.1186\/s13019-023-02169-6.","journal-title":"J Cardiothorac Surg"},{"issue":"6","key":"988_CR40","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1002\/mus.27220","volume":"63","author":"D Menon","year":"2021","unstructured":"Menon D, Katzberg H, Barnett C, et al. Thymoma pathology and myasthenia gravis outcomes. Muscle Nerve. 2021;63(6):868\u201373. https:\/\/doi.org\/10.1002\/mus.27220.","journal-title":"Muscle Nerve"}],"container-title":["Neurology and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40120-026-00988-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40120-026-00988-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T15:11:39Z","timestamp":1784819499000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40120-026-00988-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,27]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["988"],"URL":"https:\/\/doi.org\/10.1007\/s40120-026-00988-y","relation":{},"ISSN":["2193-8253","2193-6536"],"issn-type":[{"value":"2193-8253","type":"print"},{"value":"2193-6536","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,27]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Jialin Chen, Hongxi Chen, Xianglin Chu, Jie Song, Nana Zhang, Zhangyu Zou, Hui Wu, Liewen Pang, Chongbo Zhao, Hongyu Zhou, Zhitao Gu and Sushan Luo have nothing to disclose. Huahua Zhong is an Editorial Board member of\n                      Neurology and Therapy\n                      . Huahua Zhong was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions.","order":1,"name":"Ethics","label":"Conflict of Interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures involving human subjects were performed in accordance with the ethical standards formulated by the institutional and\/or national research committees, as well as the 1964 Declaration of Helsinki and its subsequent amendments or comparable ethical standards. The study was approved by the Ethics Committees of Huashan Hospital (2019-441, 2020-999, and 2022-913). All participants provided written informed consent prior to their inclusion in this study, including the permission for the use of MG-ADL score and MGFA classifications.","order":2,"name":"Ethics","label":"Ethical Approval","group":{"name":"EthicsHeading","label":"Declarations"}}]}}